
Raised $50M Series A on Feb 12, 2025
We are a frontier AI lab building generative models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering.